Production Of GSK's Ziagen HIV Oral Liquid Medicine

Paul Lucas, president and chief executive officer of GlaxoSmithKline Canada Inc., poses for a photograph in front of the production line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Lucas has been head of GlaxoSmithKline's Canadian operations since 2000. Photographer: Norm Betts/Bloomberg via Getty Images
Paul Lucas, president and chief executive officer of GlaxoSmithKline Canada Inc., poses for a photograph in front of the production line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Lucas has been head of GlaxoSmithKline's Canadian operations since 2000. Photographer: Norm Betts/Bloomberg via Getty Images
Production Of GSK's Ziagen HIV Oral Liquid Medicine
PURCHASE A LICENCE
How can I use this image?
AED 1,850.00
AED

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
107630267
Collection:
Bloomberg
Date created:
13 December, 2010
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
GLAXO